Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Neuroreport|July 28, 1997
(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's diseaseA Ekesbo, P E Andrén, L M Gunne, et al.Annals of Neurology|September 11, 1999
Regulation of dopaminergic activity in early Parkinson's diseaseJ Tedroff, A Ekesbo, E Rydin, et al.European Journal of Pharmacology|February 26, 2000
Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesionsA Ekesbo, P E Andrén, L M Gunne, et al.Neurology|January 28, 1999
Dopamine autoreceptor function is lost in advanced Parkinson's diseaseA Ekesbo, E Rydin, R Torstenson, et al.Neuropharmacology|April 29, 1999
Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brainsA Ekesbo, R Torstenson, P Hartvig, et al.European Journal of Pharmacology|February 13, 2001
Effects of acute and repeated treatment with a novel dopamine D2 receptor ligand on L-DOPA-induced dyskinesias in MPTP monkeysA Hadj Tahar, A Ekesbo, L Grégoire, et al.Pageof 1